BridgeMD
New treatment option for Nontuberculous Mycobacterial Pulmonary Disease
Official title Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease
ClinicalTrials.gov ID: NCT06488495
What this study is testing
- What it's testing
- 1.objective Evaluation of effectiveness and safety of exercise intervention program for patients with non-tuberculous mycobacterial pulmonary disease 2. background Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic respiratory infection that generally affects individuals with structural lung diseases, such as chronic obstructive pulmonary disease (COPD) and bronchiectasis and without structural lung disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Adults aged 40-80 diagnosed with NTM pulmonary disease.
- Present respiratory symptoms.
- Positive NTM culture within the last 6 months.
- Voluntary consent to participate.
You likely can't join if
- Diagnosed with cardiovascular disease.
- Recent major hemoptysis.
- Musculoskeletal issues preventing free movement.
- Unable to read the consent form.
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.